Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Director | Common Stock | 22.9K | $854K | $37.37 | Dec 15, 2023 | Direct |
Tonix Pharmaceuticals Holding Corp. | Director | Stock Option | 105K | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TNXP | Tonix Pharmaceuticals Holding Corp. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Dec 15, 2023 | 1 | $381K | 4 | Dec 19, 2023 | Director |
TNXP | Tonix Pharmaceuticals Holding Corp. | May 8, 2023 | 1 | $0 | 4 | May 10, 2023 | Director |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Mar 3, 2023 | 1 | -$371K | 4 | Mar 6, 2023 | Director |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 10, 2023 | 2 | $0 | 4 | Jan 11, 2023 | Director |
TNXP | Tonix Pharmaceuticals Holding Corp. | May 9, 2022 | 1 | $0 | 4 | May 11, 2022 | Director |
GENQ | Genesis Unicorn Capital Corp. | Feb 14, 2022 | 0 | $0 | 3 | Mar 4, 2022 | Chief Executive Officer |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 7, 2022 | 1 | $0 | 4 | Jan 7, 2022 | Director |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 3, 2022 | 3 | -$262K | 4 | Jan 4, 2022 | Director |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Sep 13, 2021 | 2 | -$319K | 4 | Sep 14, 2021 | Director |
TNXP | Tonix Pharmaceuticals Holding Corp. | May 10, 2021 | 1 | $0 | 4 | May 12, 2021 | Director |